UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Three-Dimensional Planning for Vaginal Cuff Brachytherapy: Is It Necessary at Every Fraction?

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E264-E264

2015

Link zum Volltext

Verfügbarkeit prüfen

Modelling ionization chamber response to nonstandard beam configurations

Journal of physics. Conference series, 2008-02, Vol.102 (1), p.012023

2008

Link zum Volltext

Verfügbarkeit prüfen

WE‐E‐BRA‐03: Modelling Ionisation Chamber Response to Non‐Standard Beam Configurations

Medical physics (Lancaster), 2007-06, Vol.34 (6), p.2611-2611

2007

Link zum Volltext

Verfügbarkeit prüfen

Maman, j'aime pas l'école: Les enfants d'aujourd'hui dans l'école de demain

2012

Link zum Volltext

Verfügbarkeit prüfen

Switching Adolescent High-Fat Diet to Adult Control Diet Restores Neurocognitive Alterations

Frontiers in behavioral neuroscience, 2016-11, Vol.10, p.225-225

2016

Link zum Volltext

Verfügbarkeit prüfen

The effect of high-fat diet consumption on appetitive instrumental behavior in rats

Appetite, 2017-01, Vol.108, p.203-211

2017

Link zum Volltext

Verfügbarkeit prüfen

Cutaneous apocrine adenocarcinoma in a PALB2 germline pathogenic variant carrier

Journal of the European Academy of Dermatology and Venereology, 2022-08, Vol.36 (8), p.e636-e638

2022

Link zum Volltext

Verfügbarkeit prüfen

Reconfigurable diplexer using hybrid couplers and perturbed TE012 cavities

International journal of microwave and wireless technologies, 2022-04, Vol.14 (3), p.351-361

2022

Link zum Volltext

Verfügbarkeit prüfen

Brain metastases response to nivolumab in patients with renal cell carcinoma (RCC): Prospective analysis from the GETUG-AFU 26 (NIVOREN) trial

Annals of oncology, 2018-10, Vol.29, p.viii306-viii306

2018

Link zum Volltext

Verfügbarkeit prüfen

Reconfigurable diplexer using hybrid couplers and perturbed TE 012 cavities

International journal of microwave and wireless technologies, 2022-04, Vol.14 (3), p.351-361

2022

Link zum Volltext

Verfügbarkeit prüfen

Sound and light from fractures in scintillators

Physical review letters, 2013-10, Vol.111 (15), p.154301-154301, Article 154301

2013

Link zum Volltext

Verfügbarkeit prüfen

687P NIVOREN GETUG-AFU 26 translational study: Baseline peripheral cytokines predict survival in metastatic clear cell renal carcinoma (RCC) treated with nivolumab

Annals of oncology, 2021-09, Vol.32, p.S704-S705

2021

Link zum Volltext

Verfügbarkeit prüfen

NIVOREN GETUG-AFU 26 translational study: Baseline peripheral cytokines predict survival in metastatic clear cell renal carcinoma (RCC) treated with nivolumab

Annals of oncology, 2021-09, Vol.32, p.S704-S705

2021

Link zum Volltext

Verfügbarkeit prüfen

712P Primary tumour response in patients treated with nivolumab for metastatic renal cell carcinoma (mRCC): Results of the GETUG-AFU 26 NIVOREN trial

Annals of oncology, 2020-09, Vol.31, p.S560-S561

2020

Link zum Volltext

Verfügbarkeit prüfen

972P - Fresh blood Immune cell monitoring in patients treated with nivolumab in the GETUG-AFU26 NIVOREN study: Association with toxicity and treatment outcome

Annals of oncology, 2019-10, Vol.30, p.v394-v394

2019

Link zum Volltext

Verfügbarkeit prüfen

Fresh blood Immune cell monitoring in patients treated with nivolumab in the GETUG-AFU26 NIVOREN study: Association with toxicity and treatment outcome

Annals of oncology, 2019-10, Vol.30, p.v394

2019

Link zum Volltext

Verfügbarkeit prüfen

697P Impact of β-blockers (BB) on outcomes of metastatic renal cell carcinoma (mRCC) patients treated with nivolumab (N)

Annals of oncology, 2021-09, Vol.32, p.S710-S710

2021

Link zum Volltext

Verfügbarkeit prüfen

657MO Antibiotic (ATB) therapy and outcome from nivolumab (N) in metastatic renal cell carcinoma (mRCC) patients (pts): Results of the GETUG-AFU 26 NIVOREN multicentric phase II study

Annals of oncology, 2021-09, Vol.32, p.S681-S681

2021

Link zum Volltext

Verfügbarkeit prüfen

Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC)

Annals of oncology, 2021-09, Vol.32, p.S706-S706

2021

Link zum Volltext

Verfügbarkeit prüfen

689P Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC)

Annals of oncology, 2021-09, Vol.32, p.S706-S706

2021

Link zum Volltext

Verfügbarkeit prüfen

A multi-channel setup to study fractures in scintillators

Measurement science & technology, 2016-12, Vol.27 (12), p.125601

2016

Link zum Volltext

Verfügbarkeit prüfen

Mesures multiports de dispositifs passifs par analyseur de réseaux 4 ports

Journal sur l'enseignement des sciences et technologies de l'information et des systèmes, 2022-06, Vol.21, p.1020

2022

Link zum Volltext

Verfügbarkeit prüfen

700O Kidney ccRCC immune classification (KIC) enhances the predictive value of T effector (Teff) and angiogenesis (Angio) signatures in response to nivolumab (N)

Annals of oncology, 2020-09, Vol.31, p.S553-S553

2020

Link zum Volltext

Verfügbarkeit prüfen

Kidney ccRCC immune classification (KIC) enhances the predictive value of T effector (Teff) and angiogenesis (Angio) signatures in response to nivolumab (N)

Annals of oncology, 2020-09, Vol.31, p.S553-S553

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Life Sciences & Biomedicine
(7)
Physics
(6)
Engineering Sciences
(5)
Quality Assurance
(5)
Technology
(5)
Electromagnetism
(4)
Engineering
(4)
Life Sciences
(4)
Quality Control
(4)
Electronics
(3)
Engineering, Electrical & Electronic
(3)
Humans
(3)
Physical Sciences
(3)
Physicists
(3)
Quality Management
(3)
Radiation Therapy
(3)
Radiology, Nuclear Medicine & Medical Imaging
(3)
60 Applied Life Sciences
(2)
Accreditation
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Three-Dimensional Planning for Vaginal Cuff Brachytherapy: Is It Necessary at Every Fraction?

Modelling ionization chamber response to nonstandard beam configurations

WE‐E‐BRA‐03: Modelling Ionisation Chamber Response to Non‐Standard Beam Configurations

Maman, j'aime pas l'école: Les enfants d'aujourd'hui dans l'école de demain

Switching Adolescent High-Fat Diet to Adult Control Diet Restores Neurocognitive Alterations

The effect of high-fat diet consumption on appetitive instrumental behavior in rats

Cutaneous apocrine adenocarcinoma in a PALB2 germline pathogenic variant carrier

Reconfigurable diplexer using hybrid couplers and perturbed TE012 cavities

Brain metastases response to nivolumab in patients with renal cell carcinoma (RCC): Prospective analysis from the GETUG-AFU 26 (NIVOREN) trial

Reconfigurable diplexer using hybrid couplers and perturbed TE 012 cavities

1480P Baseline levels of proinflammatory cytokines according to body mass index (BMI) and BMI impact on clinical outcomes in metastatic renal cell carcinoma (mRCC) patients (pts) treated with nivolumab (NIVO) within the NIVOREN trial

Sound and light from fractures in scintillators

687P NIVOREN GETUG-AFU 26 translational study: Baseline peripheral cytokines predict survival in metastatic clear cell renal carcinoma (RCC) treated with nivolumab

NIVOREN GETUG-AFU 26 translational study: Baseline peripheral cytokines predict survival in metastatic clear cell renal carcinoma (RCC) treated with nivolumab

712P Primary tumour response in patients treated with nivolumab for metastatic renal cell carcinoma (mRCC): Results of the GETUG-AFU 26 NIVOREN trial

972P - Fresh blood Immune cell monitoring in patients treated with nivolumab in the GETUG-AFU26 NIVOREN study: Association with toxicity and treatment outcome

Fresh blood Immune cell monitoring in patients treated with nivolumab in the GETUG-AFU26 NIVOREN study: Association with toxicity and treatment outcome

697P Impact of β-blockers (BB) on outcomes of metastatic renal cell carcinoma (mRCC) patients treated with nivolumab (N)

657MO Antibiotic (ATB) therapy and outcome from nivolumab (N) in metastatic renal cell carcinoma (mRCC) patients (pts): Results of the GETUG-AFU 26 NIVOREN multicentric phase II study

Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC)

689P Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC)

A multi-channel setup to study fractures in scintillators

Mesures multiports de dispositifs passifs par analyseur de réseaux 4 ports

700O Kidney ccRCC immune classification (KIC) enhances the predictive value of T effector (Teff) and angiogenesis (Angio) signatures in response to nivolumab (N)

Kidney ccRCC immune classification (KIC) enhances the predictive value of T effector (Teff) and angiogenesis (Angio) signatures in response to nivolumab (N)

Suchergebnisse filtern